Guidelines for inherited thrombophilia testing in children
Authors:
K. Zdráhalová 1; P. Mazánek 2; E. Zápotocká 1; J. Blatný 2
Authors‘ workplace:
Klinika dětské hematologie a onkologie, FN Motol a Homolka, Praha
1; Oddělení dětské hematologie a biochemie, FN Brno
2
Published in:
Transfuze Hematol. dnes,32, 2026, No. 3, p. 223-225.
Category:
Best Practices
doi:
https://doi.org/10.55095/CSPediatrie2026/028
Overview
The incidence of thromboembolic disease in childhood is low compared to the adult population. Thrombophilia refers to factors that increase the risk of developing thrombosis. The most important factors in the development of thrombosis in children are acquired, with central venous catheters being the leading cause. In contrast, inherited thrombophilias play only a minor role. Approved consensus guidelines based on published literature specify the indications for testing for inherited thrombophilias and the scope of such testing. Incorrectly indicated, performed, and/or interpreted testing may be misleading and potentially harmful.
Keywords:
testing – thrombophilia – indication – childhood – thrombosis – inherited thrombophilia
Sources
1. van Ommen CH, Nowak-Göttl U. Inherited thrombophilia in pediatric venous thromboembolic disease: why and who to test. Front Pediatr. 2017; 5 : 50.
2. Young G, Albisetti M, Bonduel M, et al. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation. 2008; 118 (13): 1373–1382.
3. Raffini L. Pediatric aspects of thrombophilia. In: Consultative Hemostasis and Thrombosis. 4th ed. Elsevier 2019 : 266–272.
4. Klaassen IL, van Ommen CH, Middeldorp S. Manifestations and clinical impact of pediatric inherited thrombophilia. Blood. 2015; 125 (7): 1073–1077.
5. Revel-Vilk S, Chan A, Bauman M, Massicotte P. Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. J Thromb Haemost. 2003; 1 (5): 915–921.
6. Nowak-Göttl U, van Ommen H, Kenet G. Thrombophilia testing in children: what and when should be tested? Thromb Res. 2018; 164 : 75–78.
7. Raffini L. Thrombophilia in children: who to test, how, when, and why? Hematology Am Soc Hematol Educ Program. 2008 : 228–235.
8. Khider L, Gendron N, Mauge L. Inherited thrombophilia in the era of direct oral anticoagulants. Int J Mol Sci. 2022; 23 (3): 1821.
9. Blatný J. Kdy vyšetřovat vrozená trombofilní rizika u dětí? Čes-slov Pediat. 2012; 67 (1): 60–63.
10. Trenor CC 3rd, Chung RJ, Michelson AD, et al. Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics. 2011; 127 (2): 347–357.
11. Thornburg CD, Dixon N, Paulyson-Nunez K, Ortel T. Thrombophilia screening in asymptomatic children. Thromb Res. 2008; 121 (5) : 597 – 604.
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2026 Issue 3
- Cost Effectiveness of FVIII Substitution Versus Non-Factor Therapy for Hemophilia A
- Vascular Disease in the Gradually Aging Population of Hemophiliacs: An Underestimated Problem?
- Prognostic Significance of Subclinical Joint Changes on MRI in Hemophilia
- Immunotolerance is still the goal of management of hemophilia A with inhibitor in the era of non-factor therapy
- Minimum and Optimal Factor Levels in Physically Active Hemophiliacs
-
All articles in this issue
- Guidelines for inherited thrombophilia testing in children
- Targeted treatment approaches for mantle cell lymphoma
- Asciminib – a novel drug for chronic myeloid leukemia with a distinct mechanism of action
- Multiple myeloma – from pathogenesis to modern therapy
- Emerging therapies for relapsed/refractory follicular lymphoma
- Contemporary diagnostic determination of D-dimer plasma concentration
- Evaluation of morphological changes in platelets during storage of platelet concentrates
- Transfusion and Haematology Today
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue
- Targeted treatment approaches for mantle cell lymphoma
- Multiple myeloma – from pathogenesis to modern therapy
- Emerging therapies for relapsed/refractory follicular lymphoma
- Evaluation of morphological changes in platelets during storage of platelet concentrates